Franck C.
- Country
- France
- Department
- gastroenterology
Research Overview
Data & Insights
Has run more than one trial at 0 of 42 partner sites.
Specializations
Gastroenterology & Hepatology
The investigator concentrates on inflammatory and cholestatic disorders of the digestive tract, including Crohn’s disease and ulcerative colitis, as well as liver‑related pruritus.
- Inflammatory bowel disease therapies
- Ulcerative colitis remission strategies
- Cholestatic pruritus management
- Colorectal cancer with liver metastasis
- Gut‑lung axis in obesity
Research aims to improve patient‑centered outcomes in chronic gastrointestinal conditions.
Autoimmune & Rheumatology
In the field of systemic autoimmunity, the investigator addresses juvenile idiopathic arthritis, systemic lupus erythematosus, and Sjögren’s syndrome.
- Juvenile idiopathic arthritis therapies
- Systemic lupus disease activity control
- Sjögren’s syndrome systemic manifestations
- Rheumatoid arthritis biologic optimization
- Psoriatic arthritis treatment strategies
Efforts focus on targeted modulation of immune pathways to reduce disease burden.
Neurology & Neurodegeneration
Neurological research includes demyelinating diseases such as multiple sclerosis and rare leukodystrophies.
- Multiple sclerosis relapse prevention
- MOGAD therapeutic approaches
- Metachromatic leukodystrophy disease progression
- Cerebral adrenoleukodystrophy interventions
- Diffuse intrinsic pontine glioma strategies
The work emphasizes neuroprotective interventions and quality of life improvements.
Hematology & Oncology
The investigator explores hematologic malignancies and marrow failure, notably myelodysplastic syndromes and myelofibrosis.
- Lower‑risk MDS treatment optimization
- Myelofibrosis disease‑modifying agents
- Anemia management in chronic disease
- Bone marrow fibrosis monitoring
- Transfusion independence strategies
Clinical focus is on extending survival and reducing transfusion dependence.
Rare Genetic & Metabolic Disorders
Rare inherited conditions such as hereditary transthyretin amyloidosis and X‑linked hypophosphatemia are part of the investigator’s portfolio.
- Transthyretin amyloid polyneuropathy therapies
- X‑linked hypophosphatemia bone health
- Autosomal dominant hypocalcemia treatment
- Canavan disease metabolic correction
- Hypochondroplasia growth modulation
Studies aim to translate molecular insights into disease‑modifying treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.